Amorphous nanoparticles are prepared from poorly water-soluble compounds.
The nanoparticle is stabilised by the polymer matrix which prevents any subsequent particle growth and recrystallisation.
On re-dispersion in gastro-intestinal fluid the high surface area of the amorphous nanoparticles leads to improved bioavailability.